BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29580037)

  • 41. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.
    Romero AI; Thorén FB; Brune M; Hellstrand K
    Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural Cytotoxicity Receptors in Decidua Natural Killer Cells of Term Normal Pregnancy.
    Takahashi H; Yamamoto T; Yamazaki M; Murase T; Matsuno T; Chishima F
    J Pregnancy; 2018; 2018():4382084. PubMed ID: 30155304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of natural killer cells by hepatitis C virus particles in vitro.
    Farag MM; Weigand K; Encke J; Momburg F
    Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands.
    Domaica CI; Fuertes MB; Rossi LE; Girart MV; Avila DE; Rabinovich GA; Zwirner NW
    EMBO Rep; 2009 Aug; 10(8):908-15. PubMed ID: 19498463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative analysis of human NK cell reactivity using latex beads coated with defined amounts of antibodies.
    Dorsch M; Urlaub D; Bönnemann V; Bröde P; Sandusky M; Watzl C
    Eur J Immunol; 2020 May; 50(5):656-665. PubMed ID: 32027754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion.
    Lundholm M; Schröder M; Nagaeva O; Baranov V; Widmark A; Mincheva-Nilsson L; Wikström P
    PLoS One; 2014; 9(9):e108925. PubMed ID: 25268476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
    Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
    Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.
    Al-Hubeshy ZB; Coleman A; Nelson M; Goodier MR
    J Immunol Methods; 2011 Mar; 366(1-2):52-9. PubMed ID: 21281644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer.
    Shen Y; Wang Q; Qi Y; Cui B; Zhang Z; Su J; Liu X; Lu C; Ye H; Ju Y; Lu Z
    Mol Med Rep; 2014 Aug; 10(2):977-82. PubMed ID: 24819058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.
    Fregni G; Messaoudene M; Fourmentraux-Neves E; Mazouz-Dorval S; Chanal J; Maubec E; Marinho E; Scheer-Senyarich I; Cremer I; Avril MF; Caignard A
    PLoS One; 2013; 8(10):e76928. PubMed ID: 24204708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line.
    Cheng M; Ma J; Chen Y; Zhang J; Zhao W; Zhang J; Wei H; Ling B; Sun R; Tian Z
    Cell Transplant; 2011; 20(11-12):1731-46. PubMed ID: 21669033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30.
    Luczo JM; Ronzulli SL; Tompkins SM
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33494528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.
    Magri G; Muntasell A; Romo N; Sáez-Borderías A; Pende D; Geraghty DE; Hengel H; Angulo A; Moretta A; López-Botet M
    Blood; 2011 Jan; 117(3):848-56. PubMed ID: 21030563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
    Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
    Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].
    Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A high frequency of peripheral blood NKG2D+NK and NKT cells in euthyroid patients with new onset hashimoto's thyroiditis--a pilot study.
    Guo H; Xu B; Yang X; Wang Y; Liu X; Cui C; Jiang Y
    Immunol Invest; 2014; 43(4):312-23. PubMed ID: 24328530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced Expression of Natural Killer Cell-Related Activating Receptors by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer and Their Improvement by Zoledronic Acid.
    Rahimian L; Kalantari Khandani B; Nemati M; Hoseini-Shahrestanak S; Aminizadeh N; Jafarzadeh A
    Asian Pac J Cancer Prev; 2022 May; 23(5):1661-1669. PubMed ID: 35633551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.
    Castriconi R; Cantoni C; Della Chiesa M; Vitale M; Marcenaro E; Conte R; Biassoni R; Bottino C; Moretta L; Moretta A
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4120-5. PubMed ID: 12646700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.